(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[2-[2-[2-(1-naphthyloxy)ethoxy]ethoxy]ethylamino]purin-9-yl]tetrahydrofuran-3,4-diol |
|
2-[2-(2-methyphenyl)vinyl]-4(3H)-quinazoline |
|
2-Hydroxy-7-methoxy-2-(1,1,2,2,2-pentafluoroethyl)-3H-chromen-4-one
|
|
3-[2-[2-[2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]ethoxy]ethoxy]ethylamino]-1,1-diphenyl-propan-2-one |
|
4-(3a,7a-dihydro-1H-indol-3-yl)-N-[2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]ethyl]butanamide |
|
4-[benzyl(ethyl)amino]-N-[2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]ethyl]-3-nitro-benzamide |
|
4-methyl-7-[(3,4,5-trimethoxybenzyl)oxy]-2H-chromen-2-one
|
|
5-methyl-N-[2-(2-oxo-1-azepanyl)ethyl]−2-phenyl-1,3-oxazole-4-carbox-amide |
|
Difference from host, suggested target |
|
Kinetic characterization, suggested target |
|
N(6)-substituted adenosine derivatives |
|
N,N'-(benzo[d]thiazole-2,6-diyl)bis(furan-2-carboxamide) |
|
N,N'-1,3-benzothiazole-2,6-diyldi(2-furamide)
|
|
N-[2-[2-[2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-6-yl]amino]ethoxy]ethoxy]ethyl]-4-oxo-4-(4-phenylphenyl)butanamide
|
|
N6-hydroxy-9H-purin-6-amine
|
|
N-Cyclopropyl-2-{[3-(2-oxo-1-pyrrolidinyl)benzoyl]amino}benzamide
|
|
Plasmodium specific phosphatases, suggested target |
|